Mays Cancer Ctr Uthsa Mdacc

San Antonio, Texas 78229

0 studies enrolling now · 6 studies all time

What they study most

Advanced Malignancies, Advanced Solid Tumors, Breast Cancer, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer — Running, not enrolling
• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. — Completed
• A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors — Stopped early
• Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies — Stopped early
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed